Literature DB >> 1346637

Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

C Bolden1, B Cusack, E Richelson.   

Abstract

We determined the affinity and selectivity of binding for 24 compounds: nine antimuscarinics (including some antiparkinson drugs) and 15 neuroleptics (including the atypical compounds clozapine, fluperlapine, melperone, rilapine, risperidone, tenilapine, tiosperone and zotepine) at the five human muscarinic receptor subtypes expressed in Chinese hamster ovary cells. Equilibrium dissociation constants (Kd) were obtained from competitive radioligand binding studies with [3H]quinuclidinyl benzilate and membranal preparations of these cells. As expected, QNB had the highest affinity of the compounds studied at the five receptor subtypes and was not selective (Kd ranged from 0.027-0.088 nM). Benztropine had the next highest affinity of the antimuscarinic compounds and thioridazine had the highest affinity of the neuroleptics. Among the antiparkinson drugs, biperiden was the only one selective for the m1 subtype; and among the neuroleptics, the atypical drug clozapine was also selective for the m1 subtype. This selectivity may explain clozapine's unusual efficacy in refractory schizophrenic patients and its low incidence of extrapyramidal side effects. However, because most other atypical neuroleptics studied lacked high affinity and selectivity at muscarinic receptor subtypes, it is likely that other mechanisms are involved as well.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346637

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  68 in total

1.  Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.

Authors:  N Watson; D V Daniels; A P Ford; R M Eglen; S S Hegde
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Receptor binding studies of soft anticholinergic agents.

Authors:  F Huang; P Buchwald; C E Browne; H H Farag; W M Wu; F Ji; G Hochhaus; N Bodor
Journal:  AAPS PharmSci       Date:  2001

3.  Network activity in neurons of the motor and prefrontal areas of the cortex in trained cats in conditions of systemic administration of m-cholinoreceptor blockers.

Authors:  V N Khokhlova; G Kh Merzhanova; E E Dolbakyan
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

4.  Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics.

Authors:  Fenglei Huang; Clinton E Browne; Whei-Mei Wu; Attila Juhász; Fubao Ji; Nicholas Bodor
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

5.  N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity.

Authors:  Cyrille Sur; Pierre J Mallorga; Marion Wittmann; Marlene A Jacobson; Danette Pascarella; Jacinta B Williams; Philip E Brandish; Douglas J Pettibone; Edward M Scolnick; P Jeffrey Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

6.  The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent.

Authors:  Barbara Gracious; Naomi Abe; Jane Sundberg
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

7.  The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

Authors:  Marilyn A Davies; Beth Ann Compton-Toth; Sandra J Hufeisen; Herbert Y Meltzer; Bryan L Roth
Journal:  Psychopharmacology (Berl)       Date:  2004-10-13       Impact factor: 4.530

8.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.

Authors:  H E Shannon; F P Bymaster; J C Hendrix; S J Quimby; C H Mitch
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.